Should You Hire a Vioxx Lawyer?

October 11, 2009

The deposit for filing a Vioxx contract management softwarestroke, heart attack, or sudden modification litigation housing are based car accident lawyeron releasing and marketing Vioxx as a safe alternative for chronic pain. content managementVioxx and another NSAID (non-steroidal, anti-inflammatory drugs) cash advancewere not tested long-term to choose its enduring safety factor. A few years passed before the FDA advised Merck to properly post warnings on the label. During that time-frame, thousands of doctors prescribed Vioxx to thousands of patients colorfast to the imminent health danger that place ahead.

If you or a beloved relatives member has suffered a Vioxx related heart attack, another cardiovascular problems, or a Vioxx induced stroke then you may be eligible to be part of a Vioxx collection state meet or individualist Vioxx litigation case.

How such does a Vioxx causa cost?
———
Most Vioxx law firms module accept clients on a occurrence fee basis. There is no fee, unless and until there is a recovery. If nothing is recovered during your Vioxx causa then the client pays nothing. The contingent fee is based on a pre-agreed percentage of the recovery depending on the complexity and risks involved in your Vioxx case.

What’s the disagreement between a Vioxx collection state suit, individualist litigation, and MDL (multi district litigation)?
———
In a Vioxx collection state suit, individuals who have similar cases would be \”joined together\” in a \”class\” to prosecute their claims in a \”more efficient\” manner. This process begins when seven person (or more) agrees to serve as the collection representative. This \”class rep\” is then subject to approval by the court. There’s a series of requirements that the suite reviews — but most significantly, whether the claims of the \”class rep\” are typical of the claims of another members of the planned class. The collection allegoric is proceeding not exclusive on his or her possess behalf, but also on behalf of every others who are similarly situated. In this case, there is exclusive ONE lawsuit, the termination of which binds every collection members. In order to choose if the collection module get clean and adequate representation, the suite module generally consider whether the attorney for the collection has experience in handling collection actions and/or claims similar to those of the planned class. In addition, the suite module choose whether there’s whatever conflicts in the interests of the collection members.

In individualist Vioxx litigation, each person’s lawyer prosecutes their case, apart from whatever another cases. If a lawyer has binary clients, each client would get individualist attention and would have their possess Vioxx lawsuit.

Even with individualist Vioxx litigation, whatever cases modify up in Federal court, due to a diversity of citizenship between the claimant and Merck. In these cases, the individualist claim gets temporarily consolidated with another cases in Federal court. But this consolidation is ONLY for the purposes of discovery, and does not impact the right to an individualist effort for that person’s Vioxx lawsuit. The MDL gives each person the goodness through judicial economy and efficiencies of scale. For example, if Merck is also being sued by 10,000 another Vioxx plaintiffs across the country, taking depositions in every the various jurisdictions could delay the effort date by years. But when every those individualist Vioxx lawsuits are consolidated for discovery, it helps to save time and money for the Vioxx clients. In addition, it places the Vioxx plaintiffs on a more level activity field.

A relatives member recently had a stroke. They was taking Vioxx for seven years. Should we be contacting a Vioxx law concern regarding Vioxx litigation?
—-
Yes, at least have a so you know your rights and understand what is at stake.
What are the alternatives to Vioxx?
Vioxx is a COX-2 selective, nonsteroidal anti-inflammatory drug (NSAID). Other COX-2 selective NSAIDs are Celebrex (celecoxib) and Bextra (valdecoxib). If you are considering taking Celebrex or Bextra, occurrence your student about the risks involved. Bextra has whatever serious side effects. Click here for more information about Bextra side effects.

Are Cox-2 inhibitors more effective than tralatitious NSAIDs for arthritis pain?
—–
Opinions vary. Plenty of doctors feel that Cox-2 inhibitors have seldom been shown to be more effective than tralatitious NSAIDs like ibuprofen and naproxen. If gastrointestinal safety is an issue, patients are prescribed protective drugs like proton-pump inhibitors to lower their risk even more. Cox-2 inhibitors have large and more exorbitantly pricey marketing campaigns. Cox-2 inhibitors also outlay such over tralatitious NSAIDs.

Basically, every of the NSAIDs have risks when taken long-term, for gastrointestinal (stomach) bleeding, but also kidney and liver toxicity. Vioxx is also related to the nonselective NSAIDs — ibuprofen and naproxen. Now that Vioxx has gone under the microscope perhaps the FDA module require more testing for Celebrex and Bextra.

What is rofecoxib?

Rofecoxib is the generic scientific term for the compound that is marketed as Vioxx.

Will Vioxx be recalled?

No, Merck is voluntarily withdrawing Vioxx from the marketplace; a Vioxx recall is not necessary.

Can my pharmacist continue to refill my prescription for Vioxx?
—–
No, Merck has initiated a market retraction in the United States at the medicine level. This effectuation Vioxx module no longer be obtainable at pharmacies. Talk to your student about what medication is right for you.

Can I get a defrayal on clean Vioxx?
——-
Yes. Merck requires patients to mail back the clean Vioxx in the original container, along with a medicine receipt to:
NNC Group – Merck Returns
2670 Executive Dr.
Indianapolis, IN 46241
Include a note with the patient’s name, address, and phone number. Merck module reimburse the outlay of the full prescription and regular shipping.

Will there be a Vioxx collection state suit?
——
Yes. There module be collection actions. However, we module exclusive be representing individualist plaintiffs, and NOT filing whatever collection actions.

I’m taking Vioxx now. What should I do?
——-
Consult with your student for further instructions. They may tell you to stop taking Vioxx. Merck is recommending people stop taking Vioxx.

Monheit Law handles MDL and individualist cases. They can be found at http://www.monheit.com

How such does a Vioxx causa cost?
——-
Most Vioxx law firms module accept clients on a occurrence basis. That effectuation you do not pay the law concern whatever money unless you win the case.

The Brandi Law Firm

October 11, 2009

Currently Mr. Brandi serves on the Plaintiff’s Management Committee in the Los angeles Vioxx Litigation, & she serves on the MDL Science & Discovery Committee in the national Vioxx litigation.

The Brandi Law Firm has extensive experience in drug litigation. Thomas Brandi has over 30 years of trial experience successfully taking on defective drug companies on behalf of injured people. She’s successfully represented clients injured from numerous drugs & devices including Rezulin, Phen-fen, L Tryptophan, Felbatol, breast implants, & the Dalkon Shield IUD. The Brandi Law Firm has a team of attorneys, investigators, doctors & nurses investigating Vioxx cases.

WHAT IS VIOXX?

If they represent you, Mr. Brandi will be your trial attorney. On November 13, 2004 Mr. Brandi was named Trial Lawyer of the Year for the State of Los angeles by the Consumers Attorneys of Los angeles. She’s been a finalist for Trial Lawyer of the Year for the Trial Lawyers of Public Justice (2004), Consumer Attorneys of Los angeles (2002) & San Francisco Trial Lawyers Association (1999, 2001). If you consult with any counsel, you should ask who will be working on your case, & if the case goes to trial, the identity of the trial attorneys & their courtroom trial experience.

WHY WAS VIOXX WITHDRAWN FROM THE MARKETPLACE?

The prescription drug Vioxx, manufactured by Merck & Co., is a prescription COX-2 selective, non-steroidal anti-inflammatory drug (NSAID) that was approved by the FDA in May 1999 for the relief of the signs & symptoms of osteoarthritis, for the management of acute pain in adults, & for the treatment of menstrual symptoms. Vioxx was later approved for the relief of the signs & symptoms of rheumatoid arthritis in adults & children. It became a widely prescribed medication for the relief of pain caused by arthritis.

The FDA was informed by Merck & Co., on September 27, 2004, that the Data Safety Monitoring Board for an ongoing long-term study of Vioxx (APPROVe) had recommended that the study be stopped early for safety reasons. The study was being conducted in patients at risk for developing recurrent colon polyps. The study showed an increased risk of cardiovascular events (including heart attack & stroke) in patients on Vioxx compared to placebo, particularly those who had been taking the drug for longer than 18 months. Based on this new safety information, Merck & FDA officials met the next day, September 28, 2004, & during that meeting the FDA was informed that Merck was voluntarily withdrawing Vioxx from the marketplace.

WHY WOULD I NEED AN ATTORNEY?

If you or your loved eight suffered a “cardiovascular event” (including heart attack & stroke) while taking Vioxx, there may be a causal link between the eight. If Vioxx caused the event, you are entitled to seek financial relief under personal injury & defective product liability laws.

At The Brandi Law Firm, our defective drug litigation attorney has extensive experience representing victims of injuries & people who have lost loved ones as a result of defective medication. If you reckon you may have suffered an injury or lost a loved eight as a result of taking Vioxx, contact us immediately. They will schedule a FREE CONSULTATION where you will meet with a knowledgeable defective drug lawyer.

The settlement

October 11, 2009

Three years after the popular painkiller Vioxx was removed from the market because it was linked to an increased risk of heart attack and stroke, manufacturer Merck & Co. announced it would pay $5 billion to settle thousands of lawsuits.

The settlement was four of the largest ever in civil litigation and will be used to pay some 27,000 suits. Lots of were filed for Vioxx victims by Kline & Specter, P.C., a national leader in the Vioxx litigation. The huge settlement was reached after lengthy negotiations with Merck’s lawyers. Tom Kline is a member of the Plantiff’s Steering Committee for the federal Vioxx litigation and has been described by The Wall Street Journal as a “key player” in the development of the litigation. (See stories 1 2 3)

Contact Us Today

Privacy Policyowner

Removal of Vioxx was announced Sept. 30, 2004 by the U.S. Food and Drug Administration. (See the FDA news release.) The action occurred after a study by Merck of Vioxx/rofecoxib suggested that some Vioxx users faced four times the risk of suffering a heart attack. More recent data, released September 2006, concluded that Vioxx increased heart and kidney risks, in some cases within 30 days after treatment. (Read the editorial.)

On Aug. 19, 2005, in the first verdict of a Vioxx-related personal injury lawsuit, a Texas jury found Merck liable for the 2001 death of a man who had taken the medication and awarded $253.5 million in compensatory and punitive damages to his widow. News agencies, such as CNN, projected the case “could have a profound effect on thousands of other cases filed against the company.” (See stories, CNN, New York Times)

Most recently, in April 2008, four new allegations surfaced against Merck and Vioxx. Four was that the company manipulated data to hide the increased mortality risk of the pain drug. The other was the revelation that Merck used company employees or ghostwriters to write papers lauding Vioxx and naming leading professors — who often did tiny work — as the authors. (Read editorial.)

Kline & Specter, P.C., with some 30 experienced attorneys (several of them also highly regarded doctors), is four of the nation’s leading law firms with the ability to litigate Vioxx lawsuits. Kline & Specter, based in Philadelphia and with offices in Pennsylvania, New Jersey and New York, has been among the handful of law firms spearheading the national litigation against Merck, with our Vioxx attorneys deposing ranking Merck & Co. executives and scientists.

If you or anyone you know suffered illness or death as a result of using Vioxx, you may require to contact a Vioxx lawyer for a free evaluation of your case.

Besides serving on the Plaintiff’s Steering Committee, Kline deposed key witnesses in the Vioxx litigation. Shanin Specter took the depositions of Merck CEO Ray Gilmartin, Merck Research Laboratories President Peter Kim, Merck former Senior Vice-President Alan Neis and Merck Senior Biostatistician Deborah Shapiro. Specter’s examination of Shapiro was held by New Jersey Superior Court Judge Carol Higbee to be the only evidence sufficient to support a punitive damages verdict against Merck. (View Kim deposition excerpts 1 2. View Shapiro deposition excerpts 1 2.)

VIOXX FAQs

But as Vioxx became widely used, problems arose, including serious heart ailments. Merck’s own study showed that patients who took Vioxx had a greater tendency to experience serious cardiovascular events.

Background: Vioxx was approved in the late 1990s and immediately surged toward the top of the drug sales charts as the latest and greatest in pain medication. Vioxx was considered more effective than traditional pain killers and to cause fewer gastrointestinal side effects.

KLINE & SPECTER VIOXX ATTORNEY WEBSITE

Articles in medical journals also stated that Vioxx – a Cox-2 inhibitor – may increase the risk not only of heart attack but also stroke and kidney failure.

In 2001, the U.S. Food and Drug issued a “Warning Letter” about Vioxx. It told Merck that its review of the company’s promotional activities and materials for Vioxx were “false, lacking in fair balance or otherwise misleading.” The FDA also blasted Merck for minimizing and omitting important risk information about using Vioxx along with other drugs.

* Note: Vioxx is commonly misspelled Viox.
News

Newspaper Articles
Tom Kline interview on Vioxx settlement, The Legal Intelligencer 11/12/07
Merck settles Vioxx lawsuits, Tom Kline comments, The Philadelphia Inquirer 11/10/07
Tom Kline on huge Vioxx legal effort, The Philadelphia Inquirer 11/10/07.
Tom Kline on short-term Vioxx risk Business Week 7/20/07
Tom Kline on $47.5 million Vioxx verdict, The Philadelphia Inquirer 3/13/07
Tom Kline on Vioxx trial “shadow juries,” The Star-Ledger 2/13/07
The Wall Street Journal quotes Tom Kline on New Vioxx Study, 5/12/06
Tom Kline quoted on Vioxx Risk After Use Ended, Wall Street Journal, 5/12/06
Wall Street Journal quotes Tom kline on Vioxx “Trial in a Box”, 4/17/06
Kline & Specter work called key in verdict vs. Vioxx, Legal Intelligencer, 4/12/06
Tom Kline quoted on federal Vioxx litigation, Wall Street Journal, 3/17/06
Tom Kline quoted by Wall Street Journal on federal drug labeling 1/14/06
More highs, lows expected for Merck in Vioxx trials, The Philadelphia Inquirer 11/07/05
Maker of Vioxx Says Some Suits May Be Settled, New York Times 08/26/2005
Merck Braces for More Vioxx Lawsuits, The Wall Street Journal 08/23/2005
Merck Loss Jolts Drug Giant, Industry, The Wall Street Journal 08/22/2005
Aftershocks From Vioxx Verdict, The Philadelphia Inquirer 08/20/2005
Merck & Co. Found Liable In Nation’s First Vioxx Trial, Associated Press 08/19/2005

Television Coverage
Tom Kline interview on latest Vioxx ruling, Fox News 9/07/07
Tom Kline interviewed on the latest Vioxx litigation, Fox News 1/22/07
Vioxx verdicts discussed by Tom Kline, Fox News 8/18/06
Tom Kline discusses FDA advisory board, Fox News 7/25/06
Tom Kline on the latest Vioxx verdict, Fox News 7/14/06
Tom Kline on Fox TV on the latest Vioxx revelation, 6/30/06
Tom Kline interviewed on major Vioxx verdict 4/7/06
Tom Kline interviewed by CNBC on Vioxx verdicts, 4/6/06
Tom Kline discusses Vioxx cases, Fox News 4/5/06
Tom Kline discusses Vioxx litigation on Fox News 11/02/05
Vioxx discussed with Tom Kline on The News Hour with Jim Lehrer 11/17/04
Lisa Williams and Tom Kline discuss Vioxx on Channel 13 News 10/14/04
Tom Kline on Viocxx heart attack case, Fox News 10/5/04

Hello world!

July 10, 2009

Welcome to WordPress.com. This is your first post. Edit or delete it and start blogging!


Follow

Get every new post delivered to your Inbox.